Moneycontrol
Get App
you are here: HomeNewsEconomyPolicy
Last Updated : Jan 16, 2019 08:35 PM IST | Source: Moneycontrol.com

CCI slaps penalty on Chemists and Druggists Association of Baroda

A complainant had alleged in 2009 that CDAB was limiting and controlling the supply of medicines in the market by mandating a no object certificate (NOC) before appointment of stockists before even pharma companies could introduce new products into the market.

Moneycontrol News @moneycontrolcom
Representative image
Representative image

Competition Commission of India (CCI) has slapped penalty worth Rs 32,724 on Chemists and Druggists Association of Baroda (CDAB) for indulging in restrictive trade practices.

A complainant had alleged in 2009 that CDAB was limiting and controlling the supply of medicines in the market by mandating a no object certificate (NOC) before appointment of stockists before even pharma companies could introduce new products into the market.

"Besides, there were allegations that CDAB was fixing the trade margins for the wholesalers/retailers. Subsequently, the case was transferred to the Commission by MRTPC (Monopolies and Restrictive Trade Practices Commission)," CCI said.

Close

After a detailed investigation, the competition watchdog in 2012 passed an order stating that CDAB was imposing the requirement of mandatory NOC and was also fixing margins for the wholesalers and retailers by enforcing the norms laid down by All India Organisation of Chemists and Druggists (AIOCD).

However, based on an appeal filed by CDAB, Competition Appellate Tribunal (COMPAT), which is now known as NCLAT, in November, 2016 set aside CCI’s 2012 order and remanded the matter back to the Commission for fresh adjudication.

The government had in May, 2017 dissolved COMPAT and notified that all applications filed or pending before COMPAT will now be transferred to National Company Law Appellate Tribunal (NCLAT).

After considering the matter afresh, the competition watchdog found that CDAB was indulging in ‘anti-competitive practice of insisting NOC prior to the appointment of new stockists by pharmaceutical companies and was also fixing/prescribing the trade margins.

Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months at 289. Use code FREEDOM.
First Published on Jan 16, 2019 08:31 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant